常规实践中的乳腺X线筛查:多中心研究比较数字乳腺断层合成与数字乳腺X线摄影
DBT组召回率更低(8.9% vs 10.3%),癌症检出率更高(5.3/1000 vs 4.5/1000),召回阳性预测值更高(5.9% vs 4.3%),活检率更高(17.6/1000 vs 14.5/1000),活检阳性预测值两组相似(29.3% vs 30.0%)。校正年龄、乳腺密度、中心和年份后,关联的统计学显著性保持稳定。
要点
- DBT筛查较DM召回率更低、癌症检出率更高,支持DBT作为常规筛查方式。
- DBT活检率更高但活检阳性预测值与DM相似,需关注活检指征把握。
- 阅片报告时应结合乳腺密度和年龄等因素综合评估,DBT优势在多变量校正后仍稳定。
诊断标准与关键数值
- DM组召回率10.3%(95%CI: 10.3, 10.4),DBT组8.9%(95%CI: 8.9, 9.0),P < .001。
- DM组癌症检出率4.5/1000次筛查(95%CI: 4.3, 4.6),DBT组5.3/1000次(95%CI: 5.2, 5.5),P < .001。
- DM组召回阳性预测值4.3%(95%CI: 4.2, 4.5),DBT组5.9%(95%CI: 5.7, 6.0),P < .001。
- DM组活检率14.5/1000次筛查(95%CI: 14.2, 14.7),DBT组17.6/1000次(95%CI: 17.4, 17.8),P < .001。
- DM组活检阳性预测值30.0%(95%CI: 29.2, 30.9),DBT组29.3%(95%CI: 28.7, 29.9),P = .16。
临床应用与阅片要点
- DBT筛查可降低召回率并提高癌症检出率,日常阅片可优先采用DBT进行乳腺筛查。
- DBT活检率较高但活检阳性预测值与DM相似,报告时应结合影像特征谨慎建议活检。
- 校正年龄、乳腺密度、中心和年份后DBT优势仍稳定,阅片报告可参考这些因素综合判断。
局限性
- 本研究为回顾性队列研究,可能存在残余混杂。
- 研究未报告筛查间期癌症等长期结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background The use of digital breast tomosynthesis (DBT) is increasing over digital mammography (DM) following studies demonstrating lower recall rates (RRs) and higher cancer detection rates (CDRs). However, inconsistent interpretation of evidence on the risks and benefits of mammography has resulted in varying screening mammography recommendations. Purpose To evaluate screening outcomes among women in the United States who underwent routine DM or DBT mammographic screening. Materials and Methods This retrospective cohort study included women aged 40-79 years who underwent DM or DBT screening mammograms between January 2014 and December 2020. Outcomes of RR, CDR, positive predictive value of recall (PPV1), biopsy rate, and positive predictive value of biopsy (PPV3) were compared between DM and DBT with use of adjusted multivariable logistic regression models. Results A total of 2 528 063 screening mammograms from 1 100 447 women (mean age, 57 years ± 10 [SD]) were included. In crude analyses, DBT (1 693 727 screening mammograms vs 834 336 DM screening mammograms) demonstrated lower RR (10.3% [95% CI: 10.3, 10.4] for DM vs 8.9% [95% CI: 8.9, 9.0] for DBT; P < .001) and higher CDR (4.5 of 1000 screening mammograms [95% CI: 4.3, 4.6] vs 5.3 of 1000 [95% CI: 5.2, 5.5]; P < .001), PPV1 (4.3% [95% CI: 4.2, 4.5] vs 5.9% [95% CI: 5.7, 6.0]; P < .001), and biopsy rates (14.5 of 1000 screening mammograms [95% CI: 14.2, 14.7] vs 17.6 of 1000 [95% CI: 17.4, 17.8]; P < .001). PPV3 was similar between cohorts (30.0% [95% CI: 29.2, 30.9] for DM vs 29.3% [95% CI: 28.7, 29.9] for DBT; P = .16). After adjustment for age, breast density, site, and index year, associations remained stable with respect to statistical significance. Conclusion Women undergoing digital breast tomosynthesis had improved screening mammography outcomes compared with women who underwent digital mammography. © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Bae and Seo in this issue.
引用
- Conant, Talley, Parghi, et al. Mammographic Screening in Routine Practice: Multisite Study of Digital Breast Tomosynthesis and Digital Mammography Screenings. Radiology. 2023. PMID: 36916891. doi:10.1148/radiol.221571
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。